Akero Therapeutics
Stock Forecast, Prediction & Price Target

Akero Therapeutics Financial Estimates

Akero Therapeutics Revenue Estimates

Akero Therapeutics EBITDA Estimates

Akero Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $28.07M
Low: $28.07M
High: $28.07M
avg. 0%
Avg: $58.02M
Low: $58.02M
High: $58.02M
avg. 106.69%
Avg: $216.68M
Low: $216.68M
High: $216.68M
avg. 273.43%
Net Income
 
% change YoY
$-100.73M
 
N/A
$-108.91M
 
-8.11%
$-151.75M
 
-39.34%
Avg: $-283.69M
Low: $-253.37M
High: $-193.97M
avg. -86.93%
Avg: $-306.48M
Low: $-229.25M
High: $-195.02M
avg. -8.03%
Avg: $-146.97M
Low: $-146.97M
High: $-146.97M
avg. 52.04%
Avg: $-14.04M
Low: $-14.04M
High: $-14.04M
avg. 90.44%
EBITDA
 
% change YoY
$-100.88M
 
N/A
$-111.29M
 
-10.31%
$-148.63M
 
-33.54%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$2.89
 
N/A
-$2.79
 
3.46%
-$2.89
 
-3.58%
Avg: -$4.34
Low: -$4.82
High: -$3.69
avg. -50.22%
Avg: -$4
Low: -$4.36
High: -$3.71
avg. 7.82%
Avg: -$2.8
Low: -$2.8
High: -$2.8
avg. 30.13%
Avg: -$0.27
Low: -$0.27
High: -$0.27
avg. 90.44%
Operating Expenses
 
% change YoY
$100.88M
 
N/A
$115.15M
 
14.14%
$172.87M
 
50.11%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Akero Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 11.87% in 2025-2028.

We have gathered data from 7 analysts. Their low estimate is -253.37M, average is -283.69M and high is -193.97M.

What is Akero Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 95.03% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Akero Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 19.54% in 2025-2028.

We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.82, average is -$4.34 and high is $-3.69.

What is the best performing analyst?

In the last twelve months analysts have been covering Akero Therapeutics stock. The most successful analyst is Edward Nash.